Detalhe da pesquisa
1.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936697
2.
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells.
Haematologica
; 108(1): 171-180, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678029
3.
Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study.
Blood
; 135(15): 1214-1218, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961926
4.
High total metabolic tumor volume at baseline predicts survival independent of response to therapy.
Blood
; 135(16): 1396-1405, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978225
5.
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.
Haematologica
; 107(12): 2897-2904, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35638548
6.
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study.
Hematol Oncol
; 40(4): 645-657, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606338
7.
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
Eur J Nucl Med Mol Imaging
; 48(5): 1362-1370, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097974
8.
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
Q J Nucl Med Mol Imaging
; 65(4): 410-415, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750493
9.
Current Role of Functional Imaging in the Management of Lymphoma.
Curr Oncol Rep
; 23(12): 144, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735647
10.
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
Blood
; 131(22): 2449-2453, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559480
11.
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Blood
; 131(13): 1456-1463, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437590
12.
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 20(2): 202-215, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658935
13.
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report.
Blood
; 129(19): 2616-2623, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251914
14.
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1530-1542, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30309758
15.
Quantitative FDG-PET: a new biomarker in PMBCL.
Blood
; 126(8): 924-6, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294712
16.
ΔSUVmax for interim PET in DLBCL: old is new.
Blood
; 135(25): 2202-2203, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556130
17.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
18.
[18F]-NaF PET/CT imaging in cardiac amyloidosis.
J Nucl Cardiol
; 23(4): 846-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403145
19.
FDG-PET in PMBCL: which heterogeneity?
Blood
; 132(2): 117-118, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30002045
20.
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.
Haematologica
; 105(1): e33-e36, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371411